
Carboplatin Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 50 mg/5 mL , 150 mg/15 mL, 450 mg/45 mL
Reference Brands: Paraplatin® (EU & US)
Category: Oncology Cancer Care
Carboplatin is available in Injection and strengths such as 50 mg/5 mL , 150 mg/15 mL, 450 mg/45 mL. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Carboplatin is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Carboplatin can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Carboplatin, marketed as Paraplatin®, is a platinum-based chemotherapy agent used in the treatment of various cancers, including ovarian, lung, head and neck, testicular, and bladder cancer. It is administered intravenously in 50 mg/5 mL, 150 mg/15 mL, and 450 mg/45 mL formulations. Carboplatin interferes with the DNA of cancer cells, preventing their division and growth. Manufactured under stringent GMP regulations, it offers key opportunities for B2B oncology pharmaceutical companies targeting hospitals, oncology clinics, and cancer treatment centers in the US and EU markets.
Frequently Asked Questions
Related Products
Atezolizumab
Strength:
1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength:
120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength:
12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers